Casandra
Casandra Test Code QD53714Version 1 (DRAFT)
Performing Lab
RecombX® CV2 Autoantibody Test
Also known as: CRMP-5
Clinical Use
Order TestUse
Anti‑CV2 (also known as CRMP‑5) autoantibody testing is used in the evaluation of paraneoplastic neurological syndromes, including rapidly progressive dementia. Detection of CV2/CRMP‑5 autoantibodies can support diagnosis of an underlying paraneoplastic etiology in patients presenting with neurological symptoms and suspected autoimmune or paraneoplastic processes.
Special Instructions
Not provided.
Limitations
Not provided.
Test Details
Methodology
Immunoassay (Multiplex Protein Panel)
Biomarkers
CV2 (CRMP‑5)
ProteinAutoantibody detection • Other • Binary (Detected / Not Detected)
Result Turnaround Time
3-5 days
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Serum
Volume
2 mL
Minimum Volume
0.5 mL
Container
Red top tube or Gold SST
Storage Instructions
Refrigerate serum; transfer to separate plastic vial within 48 hours
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | Ambient: 72 hours |
| Refrigerated | 28 days |
| Frozen | 28 days |
Related Tests
Other tests from different labs that may be relevant
CV2 Antibody, IgG by CBA-IFA With Reflex to Titer, Serum
ARUP Laboratories
Autoimmune Vision Loss Panel, Serum
ARUP Laboratories
Collapsin Response-Mediator Protein-5-IgG, Western Blot, Serum
Mayo Clinic Lab
Collapsin Response-Mediator Protein-5 (CRMP-5) Neuronal IgG Titer, Serum
Mayo Clinic Lab
Paraneoplastic, Autoantibody Profile
Labcorp
Autoimmune Dementia Profile
Labcorp
Dementia, Autoimmune/Paraneoplastic Evaluation, Serum
Mayo Clinic Lab
Autoimmune Neurology/Comprehensive Paraneoplastic Profile
Labcorp
Paraneoplastic Vision Loss Evaluation, Serum
Mayo Clinic Lab
Axonal Neuropathy, Autoimmune/Paraneoplastic Evaluation, Serum
Mayo Clinic Lab